Barclays’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Sell |
4,854
-49,255
| -91% | -$50.7K | ﹤0.01% | 4211 |
|
|
2025
Q1 | $53K | Sell |
54,109
-22,904
| -30% | -$22.4K | ﹤0.01% | 3874 |
|
|
2024
Q4 | $121K | Buy |
77,013
+12,924
| +20% | +$20.3K | ﹤0.01% | 3751 |
|
|
2024
Q3 | $235K | Buy |
64,089
+46,997
| +275% | +$172K | ﹤0.01% | 3401 |
|
|
2024
Q2 | $57K | Buy |
+17,092
| New | +$57K | ﹤0.01% | 3623 |
|
|
2023
Q2 | – | Sell |
-118,223
| Closed | -$474K | – | 4375 |
|
|
2023
Q1 | $474K | Sell |
118,223
-829,828
| -88% | -$3.33M | ﹤0.01% | 2678 |
|
|
2022
Q4 | $1.27M | Buy |
948,051
+400
| +0% | +$536 | ﹤0.01% | 1957 |
|
|
2022
Q3 | $1.87M | Hold |
947,651
| – | – | ﹤0.01% | 1704 |
|
|
2022
Q2 | $2.26M | Sell |
947,651
-1,736
| -0.2% | -$4.13K | ﹤0.01% | 1511 |
|
|
2022
Q1 | $3.84M | Buy |
+949,387
| New | +$3.84M | ﹤0.01% | 1323 |
|